Despite these observations, no clear host-response pathways have been identified as essential to colibactin sensitization, limiting our ability to predict host genetic factors that may increase the risk of CRC resulting from the presence of pks+ bacteria in the intestinal tract. The gene discussed is ARAF; the disease is colorectal carcinoma.